semaglutide crohn's What had GI clinicians reading in June? π Our Top 5 stories covered GLP-1s, EoE, disease guidelines, colonoscopy screening, and advanced IBD therapies. Catch up on June's biggest reads: https://t.co/KBcUktTOf3 #gastroenterology Weight Loss Medications & IBD
Description
Our premium GLP-1 product is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
doi: 10.1016/s0014-5793(02)03492-0
Al momento, orforglipron approvato negli Stati Uniti con il nome Foundayo
However, the above-linked study doesn't appear to be published in any peer-reviewed journals
Fitty Tip: Instead of focusing on eating more protein, focus on choosing less processed protein sources whenever possible
The Metabolic Basis of Nonalcoholic Steatohepatitis
